Cyclacel Pharmaceuticals (CYCC)
NASDAQ:CYCC
Holding CYCC?
Track your performance easily

Cyclacel Pharmaceuticals (CYCC) Income Statement

657 Followers

Cyclacel Pharmaceuticals Income Statement

Last quarter (Q2 2024), Cyclacel Pharmaceuticals's total revenue was $4.00K, a decrease of -98.93% from the same quarter last year. In Q2, Cyclacel Pharmaceuticals's net income was $-3.26M. See Cyclacel Pharmaceuticals’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 23Dec 22Dec 21Dec 20Dec 19
Total Revenue
$ 80.00K$ 420.00K----
Cost of Revenue
------
Gross Profit
$ 80.00K$ 420.00K----
Operating Expense
$ 20.28M$ 25.87M$ 27.66M$ 22.94M$ 10.64M$ 9.68M
Operating Income
$ -20.20M$ -25.45M$ -27.66M$ -22.94M$ -10.64M$ -9.68M
Net Non Operating Interest Income Expense
$ 75.00K$ 266.00K$ 210.00K$ 16.00K$ 42.00K$ 224.00K
Other Income Expense
$ -313.00K$ -364.00K$ 1.53M$ -144.00K$ -891.00K$ -231.00K
Pretax Income
$ -20.36M$ -25.55M$ -25.91M$ -22.73M$ -9.68M$ -9.13M
Tax Provision
$ -2.86M$ -3.00M$ -4.72M$ -3.73M$ -1.24M$ -1.30M
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -17.61M$ -22.76M$ -21.40M$ -18.66M$ -12.42M$ -8.03M
Basic EPS
$ -16.18$ -26.75$ -28.50$ -32.10$ -51.30-
Diluted EPS
$ -16.18$ -26.75$ -28.50$ -32.10$ -51.30$ -9.80
Basic Average Shares
$ 7.56M$ 852.37K$ 750.38K$ 595.08K$ 242.22K$ 816.09K
Diluted Average Shares
$ 7.56M$ 852.37K$ 750.38K$ 595.08K-$ 798.98K
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 20.28M$ 25.87M$ 27.66M$ 22.94M$ 10.64M$ 9.68M
Net Income From Continuing And Discontinued Operation
$ -17.51M$ -22.55M$ -21.20M$ -18.46M$ -8.45M$ -7.83M
Normalized Income
$ -17.56M$ -28.55M-$ -26.58M--
Interest Expense
------
EBIT
$ -20.17M$ -25.45M$ -27.66M$ -22.39M$ -10.64M$ -9.13M
EBITDA
$ -20.16M$ -25.42M$ -27.62M$ -22.35M$ -10.62M$ -9.11M
Currency in USD

Cyclacel Pharmaceuticals Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis